Infex Therapeutics Holdings plc

“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning

“I’m optimistic when it comes to both the integration and the impact of transformative technologies across the life sciences industry,” said Jessica Federer , Bayer ’s former chief digital officer a

The Review on Antimicrobial Resistance (AMR) was commissioned in July 2014 by the UK Prime Minister at the time, David Cameron, who asked economist Jim O’Neill to analyze the global problem of rising